From: Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled
Comparison
OR
95% CI
p Value
Sex
Female vs. male
0.25
0.02
1.79
0.17
SDAI at initiation of bDMARD
1 increase
0.95
0.88
1.03
0.20
Bone erosion by ultrasound
Presence vs. absence
8.35
1.78
53.2
0.017